Literature DB >> 11023456

Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis.

N Akhyani1, R Berti, M B Brennan, S S Soldan, J M Eaton, H F McFarland, S Jacobson.   

Abstract

Human herpesvirus (HHV)-6 has been associated with the pathogenesis of multiple sclerosis (MS) on the basis of serologic, molecular, and histopathologic studies. This study sought to determine the distribution of HHV-6 in different MS body fluids, including serum, saliva, urine, and peripheral blood lymphocytes. The study results extend the observation of an increased frequency of HHV-6 DNA in serum of patients with MS to the unique detection of viral sequences in urine of a subset of patients with MS. Moreover, the HHV-6 identified in these cell-free compartments was predominantly the HHV-6A variant, which has been reported to be neurotropic. These results support the hypothesis that HHV-6 may contribute to the MS disease process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023456     DOI: 10.1086/315893

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  58 in total

Review 1.  Human herpesvirus 6 infection as a trigger of multiple sclerosis.

Authors:  Konstantine I Voumvourakis; Dimitrios K Kitsos; Sotirios Tsiodras; George Petrikkos; Eleftherios Stamboulis
Journal:  Mayo Clin Proc       Date:  2010-10-06       Impact factor: 7.616

2.  Variant-specific tropism of human herpesvirus 6 in human astrocytes.

Authors:  Donatella Donati; Elena Martinelli; Riccardo Cassiani-Ingoni; Jenny Ahlqvist; Jean Hou; Eugene O Major; Steve Jacobson
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Pathogen or Bystander: Clinical Significance of Detecting Human Herpesvirus 6 in Pediatric Cerebrospinal Fluid.

Authors:  Utsav Pandey; Alexander L Greninger; Greg R Levin; Keith R Jerome; Vikram C Anand; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

4.  Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms.

Authors:  M Mayne; C Cheadle; S S Soldan; C Cermelli; Y Yamano; N Akhyani; J E Nagel; D D Taub; K G Becker; S Jacobson
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 5.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Authors:  Ronen Borenstein; Oded Singer; Adi Moseri; Niza Frenkel
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death.

Authors:  Hong Kong; Quinton Baerbig; Laine Duncan; Nick Shepel; Michael Mayne
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

Review 8.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

9.  Identification of the human herpesvirus 6A gQ1 domain essential for its functional conformation.

Authors:  Takahiro Maeki; Mayuko Hayashi; Akiko Kawabata; Huamin Tang; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

Review 10.  Human herpes virus 6B: a possible role in epilepsy?

Authors:  William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.